Want to see AKTS full AI Analyst Report?
Aktis Oncology, Inc. (AKTS) Ownership Overview
47.33% Insiders
4.30% Mutual Funds
44.27% Other Institutional Investors
3.82% ETFs
0.29% Public Companies and
Individual Investors
The ownership structure of Aktis Oncology, Inc. (AKTS) stock is a mix of institutional, retail, and individual investors. Approximately 52.38% of the company’s stock is owned by Institutional Investors, 47.33% is owned by Insiders, and 0.29% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 21, 2026 | xxxxxxxxxxxxx | $119263 | |
Jul 20, 2026 | xxxxxxxxxxxxx | $77238 | |
Jul 10, 2026 | xxxxxxxxxxxxx | $1387262 | |
Jul 10, 2026 | xxxxxxxxxxxxx | $1388494 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $42363273 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,260,064 | Insider | 19.09% | 277,534,731 | |
| 10,260,064 | Insider | 19.09% | 277,534,731 | |
| 4,235,403 | Insider | 7.88% | 114,567,651 | |
| 2,023,644 | Institution | 3.77% | 54,739,570 | |
| 1,314,405 | Institution | 2.45% | 35,554,655 | |
| 996,351 | Institution | 1.85% | 26,951,295 | |
| 941,732 | Institution | 1.75% | 25,473,851 | |
| 782,713 | Institution | 1.46% | 21,172,387 | |
| 347,305 | Insider | 0.65% | 9,394,600 | |
| 202,787 | Institution | 0.38% | 5,485,388 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,023,644 | Institution | 3.77% | 54,739,570 | |
| 202,787 | Institution | 0.38% | 5,485,388 | |
| 58,126 | Institution | 0.11% | 1,572,308 | |
| 24,468 | Institution | 0.05% | 661,859 | |
| 1,597 | Institution | <0.01% | 43,199 | |
| 1,087 | Institution | <0.01% | 29,403 | |
| 270 | Institution | <0.01% | 7,304 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 585,135 | Institution | 1.09% | 12,913,929 | |
| 542,293 | Institution | 1.01% | 14,669,026 | |
| 214,149 | Institution | 0.40% | 4,726,268 | |
| 136,470 | Institution | 0.25% | 3,691,514 | |
| 119,042 | Institution | 0.22% | 2,627,257 | |
| 87,719 | Institution | 0.16% | 2,337,711 | |
| 67,684 | Institution | 0.13% | 1,803,779 | |
| 59,273 | Institution | 0.11% | 1,603,335 | |
| 45,100 | Institution | 0.08% | 1,201,915 | |
| 34,196 | Institution | 0.06% | 925,002 |
FAQ
Who Owns Aktis Oncology, Inc. (AKTS)?
According to the latest TipRanks data, approximately 44.27% of the company's stock is held by institutional investors, 47.33% is held by insiders, and 0.29% is held by retail investors.
What percentage of Aktis Oncology, Inc. (AKTS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 44.27% of Aktis Oncology, Inc. (AKTS) stock is held by institutional investors.
What percentage of Aktis Oncology, Inc. (AKTS) stock is held by retail investors?
According to the latest TipRanks data, approximately 0.29% of Aktis Oncology, Inc. (AKTS) stock is held by retail investors.
Who owns the most shares of Aktis Oncology, Inc. (AKTS)?
MPM BIOVENTURES 2018, L.P. owns the most shares of Aktis Oncology, Inc. (AKTS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.